Sales of Actos have increased significantly in recent
years, due to potential concerns about side
effects of Avandia. However, recent research suggests that Actos side effects
are also a potential concern for diabetes patients. Concerns about the
potential risk of Actos cancer side effects first surfaced when it was
discovered that rats given the drug had a higher rate of bladder tumors. Recent
results from an on-going 10 year study, involving nearly 200,000 patients with
diabetes, suggests that there may be a risk of Actos bladder cancer the
longer the medication is taken. All of the Actos lawsuits involving cancer include similar
